VivaLNK, a California-based provider of connected healthcare for remote patient monitoring (RPM), has expanded its medical data platform through European partners.

The platform is designed for rapid development and deployment of RPM applications, and ensures patient vitals can be captured continuously from any location and delivered to clinical applications.

The company has added CardioCalm in Italy, Avittia in Greece and Current Health in the UK to its European partners. Current Health, founded in Scotland and now serving the US and UK markets, is a full-service remote healthcare platform to monitor, manage and engage patients at home.

“With VivaLNK’s continuous temperature sensor, the data are automatically captured 24 hours a day, allowing our solution to provide a more complete and accurate picture of the patient’s condition,” said Chris McCann, CEO of Current Health.

Built on a foundation of VivaLNK’s continuous medical wearable sensors for monitoring human vitals, the medical data platform powers RPM and telemedicine for more than 90 digital healthcare technology companies, and includes applications such as pharmaceutical clinical trials, cardiac monitoring, and remote and in-patient vitals monitoring. The expansion of the platform includes:

• Vitals data service – a turnkey method for continuous remote patient data capture and delivery for clinical trials and providers.
• Sensor data kit – a development kit for healthcare application developers to integrate medical wearable sensors into their products. The kit includes wearable sensors for human vitals, software tools, and developer support to build and deploy healthcare applications.

RPM in the real world not only needs to address technical challenges, but also human factors involved with user adherence, requiring a quantitative and a qualitative approach. On the technical side, one of the most common issues is interruptions in the data network.

“Our growing capabilities and offerings allow us to power more remote care around the world, taking on the heavy burden of trustworthy data capture and transmission so our partners can focus on their given application or therapeutic area,” said Jiang Li, CEO of VivaLNK. “This helps to democratise healthcare by enabling rapid innovation with cost effective approaches.”